Authentification abonné
lvrea
Accueil Tous les numéros Volume 26 / Numéro 3 (Mai 2017) Méd. Intensive Réa., 26 3 (2017) 246-255 Références
Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 26, Numéro 3, Mai 2017
Infectieux
Page(s) 246 - 255
Section Comptes-rendus de congrès / Congresses, conferences
DOI https://doi.org/10.1007/s13546-017-1279-7
Publié en ligne 22 avril 2017
  • Jouan Y, Si-Tahar M, Guillon A, (2017) Immunité de la muqueuse respiratoire : physiologie et implications en réanimation. Méd Intensive Réa 26: 11–20 [Google Scholar]
  • Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M, (2005) Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 280: 5571–5580 [CrossRef] [PubMed] [Google Scholar]
  • Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M, (2007) Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 178: 3368–3372 [CrossRef] [PubMed] [Google Scholar]
  • Le Goffic R, Balloy V, Lagranderie M, Fujita T, Meurs E, Chignard M, Si-Tahar M, (2006) Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2: e53 [CrossRef] [PubMed] [Google Scholar]
  • Si-Tahar M, Blanc F, Furio L, Chopy D, Balloy V, Lafon M, Chignard M, Fiette L, Langa F, Charneau P, Pothlichet J, (2014) Protective role of LGP2 in influenza virus pathogenesis. J Infect Dis 210: 214–223 [CrossRef] [PubMed] [Google Scholar]
  • Blanc F, Furio L, Moisy D, Yen HL, Chignard M, Letavernier E, Naffakh N, Mok CK, Si-Tahar M, (2016) Targeting host calpain proteases decreases influenza A virus infection. Am J Physiol Lung Cell Mol Physiol 310: L689–699 [CrossRef] [PubMed] [Google Scholar]
  • Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H, (2011) Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146: 980–991 [CrossRef] [PubMed] [Google Scholar]
  • Boilard E, Paré G, Rousseau M, Cloutier N, Dubuc I, Lévesque T, Borgeat P, Flamand L, (2014) Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation. Blood 123: 2854–2863 [CrossRef] [Google Scholar]
  • Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B, (2013) PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 123: 206–214 [CrossRef] [PubMed] [Google Scholar]
  • Lê VB, Schneider JG, Boergeling Y, Boergeling Y, Berri F, Ducatez M, Guerin JL, Adrian I, Errazuriz-Cerda E, Frasquilho S, Antunes L, Lina B, Bordet JC, Jandrot-Perrus M, Ludwig S, Riteau B, (2015) Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med 191: 804–819 [CrossRef] [PubMed] [Google Scholar]
  • Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errázuriz P, Martín-Pellicer A, Lorente JA, Frutos-Vivar F, (2013) Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 1: 395–401 [CrossRef] [Google Scholar]
  • Selman M, King TE, Pardo A, American Thoracic Society; European Respiratory Society; American College of Chest Physicians, (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136–151 [CrossRef] [PubMed] [Google Scholar]
  • Jaffré S, Dehoux M, Paugam C, Grenier A, Chollet-Martin S, Stern JB, Mantz J, Aubier M, Crestani B, (2002) Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. Am J Physiol Lung Cell Mol Physiol 282: L310–315 [CrossRef] [PubMed] [Google Scholar]
  • Ulich TR, Yi ES, Longmuir K, Yin S, Biltz R, Morris CF, Housley RM, Pierce GF, (1994) Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 93: 1298–1306 [CrossRef] [PubMed] [Google Scholar]
  • Quesnel C, Marchand-Adam S, Fabre A, Marchal-Somme J, Philip I, Lasocki S, Leçon V, Crestani B, Dehoux M, (2008) Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 294: L334–343 [CrossRef] [PubMed] [Google Scholar]
  • Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD, (2008) The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14: 45–54 [CrossRef] [PubMed] [Google Scholar]
  • Piednoir P, Quesnel C, Nardelli L, Leçon V, Bouadma L, Lasocki S, Philip I, Mailleux A, Soler P, Crestani B, Dehoux M, (2012) Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway. Crit Care Med 40: 2041–2049 [CrossRef] [PubMed] [Google Scholar]
  • Pilling D, Roife D, Wang M, Ronkainen SD, Crawford JR, Travis EL, Gomer RH, (2007) Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 179: 4035–4044 [CrossRef] [PubMed] [Google Scholar]
  • Quesnel C, Piednoir P, Gelly J, Nardelli L, Garnier M, Leçon V, Lasocki S, Bouadma L, Philip I, Elbim C, Mentré F, Soler P, Crestani B, Dehoux M, (2012) Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury. Crit Care Med 40: 21–28 [CrossRef] [PubMed] [Google Scholar]
  • Garnier M, Mailleux AA, Besnard V, Abback PS, Leçon V, Neuville M, Gouel A, Crestani B, Dehoux M, Quesnel C, (2016) Serum Amyloid P Contained in Alveolar Fluid From Patients With Acute Respiratory Distress Syndrome Mediates the Inhibition of Monocyte Differentiation into Fibrocyte. Crit Care Med 44: e563–573 [CrossRef] [PubMed] [Google Scholar]
  • Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, Rogers AJ, Levitt J, Wiener-Kronish J, Bajwa EK, Leavitt A, McKenna D, Thompson BT, Matthay MA, (2015) Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med 3: 24–32 [CrossRef] [Google Scholar]
  • Shyamsundar M, McAuley DF, Ingram RJ, Gibson DS, O’Kane D, McKeown ST, Edwards A, Taggart C, Elborn JS, Calfee CS, Matthay MA, O’Kane CM, (2014) Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury. Am J Respir Crit Care Med 189: 1520–1529 [CrossRef] [PubMed] [Google Scholar]
  • Cross LJM, O’Kane CM, McDowell C, Elborn JJ, Matthay MA, McAuley DF, (2013) Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction--a randomised placebo-controlled trial (KARE): study protocol. Trials 14: 51 [CrossRef] [PubMed] [Google Scholar]
  • Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A, (2004) Neutrophil extracellular traps kill bacteria. Science 303: 1532–1535 [CrossRef] [PubMed] [Google Scholar]
  • Mantovani A, Cassatella MA, Costantini C, Jaillon S, (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11: 519–531 [CrossRef] [PubMed] [Google Scholar]
  • Prost N de, Ricard JD, Saumon G, Dreyfuss D, (2011) Ventilator-induced lung injury: historical perspectives and clinical implications. Ann Intensive Care 1: 28 [CrossRef] [PubMed] [Google Scholar]
  • Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS, (1997) Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99: 944–952 [CrossRef] [PubMed] [Google Scholar]
  • Bouadma L, Dreyfuss D, Ricard J-D, Martet G, Saumon G, (2007) Mechanical ventilation and hemorrhagic shock-resuscitation interact to increase inflammatory cytokine release in rats. Crit Care Med 35: 2601–2606 [CrossRef] [PubMed] [Google Scholar]
  • Musch G, Venegas JG, Bellani G, Winkler T, Schroeder T, Petersen B, Harris RS, Melo MF, (2007) Regional gas exchange and cellular metabolic activity in ventilator-induced lung injury. Anesthesiology 106: 723–735 [CrossRef] [PubMed] [Google Scholar]
  • Costa EL, Musch G, Winkler T, Schroeder T, Harris RS, Jones HA, Venegas JG, Vidal Melo MF, (2010) Mild endotoxemia during mechanical ventilation produces spatially heterogeneous pulmonary neutrophilic inflammation in sheep. Anesthesiology 112: 658–669 [CrossRef] [PubMed] [Google Scholar]
  • Wellman TJ, Prost N de, Tucci M, Winkler T, Baron RM, Filipczak P, Raby B, Chu JH, Harris RS, Musch G, Dos Reis Falcao LF, Capelozzi V, Venegas JG, Vidal Melo MF, (2016) Lung Metabolic Activation as an Early Biomarker of Acute Respiratory Distress Syndrome and Local Gene Expression Heterogeneity. Anesthesiology 125: 992–1004 [CrossRef] [PubMed] [Google Scholar]
  • McAuley DF, Laffey JG, O’Kane CM, Perkins GD, Mullan B, Trinder TJ, Johnston P, Hopkins PA, Johnston AJ, McDowell C, McNally C; HARP-2 Investigators; Irish Critical Care Trials Group, (2014) Simvastatin in the acute respiratory distress syndrome. N Engl J Med 371: 1695–1703 [CrossRef] [PubMed] [Google Scholar]
  • Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA; NHLBI ARDS Network, (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2: 611–620 [CrossRef] [Google Scholar]
  • Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, Calfee CS; ARDS Network, (2017) Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy. Am J Respir Crit Care Med 195: 331–338 [PubMed] [Google Scholar]
  • Josset L, Textoris J, Loriod B, Ferraris O, Moules V, Lina B, N’guyen C, Diaz JJ, Rosa-Calatrava M, (2010) Gene expression signature-based screening identifies new broadly effective influenza a antivirals. PloS One 5: e13169 [CrossRef] [PubMed] [Google Scholar]
  • Lamb J, (2007) The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 7: 54–60 [CrossRef] [PubMed] [Google Scholar]
  • Gilbert BE, McLeay MT, (2008) MegaRibavirin aerosol for the treatment of influenza A virus infections in mice. Antiviral Res 78: 223–229 [CrossRef] [PubMed] [Google Scholar]
  • Adegunsoye A, Strek ME, Garrity E, Guzy R, Bag R, (2016) Comprehensive Care of the Lung Transplant Patient. Chest [in press] [Google Scholar]
  • Orens JB, Boehler A, Perrot M de, Estenne M, Glanville AR, Keshavjee S, Kotloff R, Morton J, Studer SM, Van Raemdonck D, Waddel T, Snell GI; Pulmonary Council, International Society for Heart and Lung Transplantation, (2003) A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 22: 1183–1200 [CrossRef] [PubMed] [Google Scholar]
  • Sage E, Mussot S, Trebbia G, Puyo P, Stern M, Dartevelle P, Chapelier A, Fischler M; Foch Lung Transplant Group, (2014) Lung transplantation from initially rejected donors after ex vivo lung reconditioning: the French experience. Eur J CardioThorac Surg 46: 794–799 [CrossRef] [PubMed] [Google Scholar]
  • Cypel M, Yeung JC, Liu M, Anraku M, Chen F, Karolak W, Sato M, Laratta J, Azad S, Madonik M, Chow CW, Chaparro C, Hutcheon M, Singer LG, Slutsky AS, Yasufuku K, de Perrot M, Pierre AF, Waddell TK, Keshavjee S, (2011) Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 364: 1431–1440 [CrossRef] [PubMed] [Google Scholar]
  • Valenza F, Rosso L, Coppola S, Froio S, Palleschi A, Tosi D, Mendogni P, Salice V, Ruggeri GM, Fumagalli J, Villa A, Nosotti M, Santambrogio L, Gattinoni L, (2014) Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation. Transpl Int 27: 553–561 [CrossRef] [PubMed] [Google Scholar]
  • De Wolf J, Puyo P, Bonnette P, Roux A, Le Guen M, Parquin F, Chapelier A, Sage E, (2016) Logistic ex Vivo Lung Perfusion for Hyperimmunized Patients. Ann Thorac Surg 102: e205–206 [CrossRef] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.